Clinical trials: Primary Enuresis
- Condition Primary Enuresis
- Funder type Industry (pharma, biotech, devices)
- Accepts healthy volunteers yes
Primary Nocturnal Enuresis
A 6-week Open Label Cross-over Study With 2 Different Daily Doses of Minirin® Oral Lyophilisate in Children and Adolescents With Primary Nocturnal Enuresis (PNE)
To evaluate the preference of subjects for Minirin® oral lyophilisate treatment compared with Minirin® tablet treatment after 6 weeks.
- Trial name
- PALAT (NCT00209261)
- Testing
- MINIRIN Oral Lyophilisate, Minirin tablet
- Where
- France
- Volunteers
- 221 people, healthy volunteers welcome
- Sponsor
- Ferring Pharmaceuticals